Medication info
Mericl Tablet (Glimepiride)

Mericl Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Daiwon Pharmaceutical Co., Ltd.
Appearance
Green oblong tablet
Packaging
Domestic: 30 tablets (10 tablets/PTP x 3), 300 tablets/bottle, Export: 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 200401747 · Notified 2004.06.24 · Insurance code 671801610

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching to this medicine from another oral blood glucose-lowering medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is used in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Ingredients

Manufacturer
Daiwon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is prescribed to assist in blood sugar control for patients with type 2 diabetes. Patients can effectively manage their blood sugar levels by taking this medication, in addition to meals and exercise. It is effective when used alone, but it can also be combined with other blood glucose-lowering agents or insulin in certain cases. Co-administration is particularly recommended when sufficient control is difficult with other oral hypoglycemic agents. Thus, this medication helps improve blood sugar control in conjunction with various treatment options.

How to take

Adult dose

Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. Take this medicine before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose determination For patients who have not previously received medication, start treatment with 1 mg of glimepiride once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. Generally, there is little additional benefit with doses above 4 mg, but some patients have achieved better metabolic control by increasing the dose to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the need for this medicine may decrease. Therefore, dose reduction or discontinuation of this medicine may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering medicine to this medicine There is no exact dose equivalence between this medicine and other oral blood glucose-lowering medicines. When switching to this medicine from another oral blood glucose-lowering medicine, it is recommended to follow the method described under Initial dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) levels is also recommended. In general, hypoglycemia can be promptly corrected by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully treated initially during administration of a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and may sometimes require hospitalization. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it at approximately weekly intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is used in combination with metformin, and the risk may increase. Appropriate caution should be exercised.

Precautions

This medication should not be used in patients with insulin-dependent diabetes or those experiencing diabetic ketoacidosis or coma. Patients with allergies to this medication, its components, or sulfonylureas should also refrain from taking it. It is not to be used in patients with severely diminished liver or kidney function, and insulin therapy is recommended in such cases. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe infections, or those undergoing surgery or suffering from serious trauma should also be recommended insulin therapy instead of this medication. Patients with gastrointestinal disorders such as diarrhea or vomiting are at risk for hypoglycemia due to poor food absorption, so caution is needed. During the initial week of treatment, there is a high risk of hypoglycemia, so blood sugar levels should be carefully monitored, particularly in the elderly, those with poor nutritional status or irregular eating habits, and patients who consume alcohol frequently. Patients with weakened kidney or liver function, or those with other endocrine disorders or excessive medication use also face an increased risk of hypoglycemia that necessitates careful management. This medication may cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. If hypoglycemic symptoms occur, sugar should be ingested immediately, and consultation with medical personnel should follow. Various side effects can occur, including blurred vision, indigestion, liver dysfunction, blood abnormalities, and allergic reactions. Therefore, any abnormal symptoms should be reported to a doctor immediately. This medication must be taken regularly alongside dietary and exercise regimens, and it is essential to consistently confirm blood sugar control. In the event of hypoglycemia, consumption of sugar or sugar-containing drinks can alleviate symptoms, so it is advisable to always carry some form of sugar. When taking this medication alongside other drugs, it may affect blood sugar control due to interactions, so patients must inform their doctor or pharmacist about all medications they are taking. In particular, since this medication is metabolized in the liver, dosage adjustments may be necessary when used with drugs that affect liver metabolism. Pregnant or nursing women should avoid this medication to prevent harm to the fetus or newborn and switch to insulin therapy as a safer option. Children should not use this medication as its safety and efficacy have not been established for them. Elderly patients may have delayed excretion of the medication due to decreased kidney function, necessitating careful dose adjustments. In the case of overdose, severe hypoglycemia may occur, requiring immediate emergency treatment such as inducing vomiting, gastric lavage, or glucose injection.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, partial paralysis, sensory disturbances, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, severe venous thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius. This helps maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

Domestic: 30 tablets (10 tablets/PTP x 3), 300 tablets/bottle, Export: 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.